Open AccessExtracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants
Author(s) -
Bern Murray M.
Publication year - 2017
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1186/s40169-017-0165-2
Subject(s) - microbiology and biotechnology , microvesicles , endothelium , vesicle , angiogenesis , cytosol , extracellular , extracellular vesicle , cell , extracellular vesicles , cell membrane , extracellular matrix , chemistry , cancer research , biology , membrane , biochemistry , endocrinology , microrna , gene , enzyme
Extracellular vesicles (EV) are blebs of cellular membranes, which entrap small portions of subjacent cytosol. They are released from a variety of cells, circulate in the blood for an unknown length of time and come to rest on endothelial surfaces. They contribute to an array of physiologic pathways, the complexity of which is still being investigated. They contribute to metastatic malignant cell implants and tumor‐related angiogenesis, possibly abetted by the tissue factor that they carry. It is thought that the adherence of the EV to endothelium is dependent upon a combination of their P‐selectin glycoprotein ligand‐1 and exposed phosphatidylserine, the latter of which is normally hidden on the inner bilayer of the intact cellular membrane. This manuscript reviews what is known about EV origins, their clearance from the circulation and how they contribute to malignant cell implants upon endothelium surfaces and subsequent tumor growth.